| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA810198 | F | In vitro cytotoxicity against mouse TLX5 lymphoma cells | Mus musculus | 19 | cell-based format | Scientific Literature | ||
| 2. | ALA810199 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,ip) at the dose of 160 mg/kg on 5th day | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA810200 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,ip) at the dose of 320 mg/kg on 5th day | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA812042 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,ip) at the dose of 80 mg/kg on 5th day | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA812043 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 10 mg/kg on 5th day | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 6. | ALA812044 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 160 mg/kg | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 7. | ALA812045 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 160 mg/kg on 5th day | Mus musculus | 9 | organism-based format | Scientific Literature | ||
| 8. | ALA812046 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 20 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA812047 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 20 mg/kg on 5th day | Mus musculus | 12 | organism-based format | Scientific Literature | ||
| 10. | ALA812048 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 320 mg/kg on 4th day | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA812049 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 320 mg/kg on 5th day | Mus musculus | 7 | organism-based format | Scientific Literature | ||
| 12. | ALA812050 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 40 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA812051 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 40 mg/kg on 5th day | Mus musculus | 12 | organism-based format | Scientific Literature | ||
| 14. | ALA812722 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 5 mg/kg on 5th day | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 15. | ALA812723 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 640 mg/kg on 5th day | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA812724 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 80 mg/kg on 5th day | Mus musculus | 11 | organism-based format | Scientific Literature | ||
| 17. | ALA812725 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,sc) at the dose of 80 mg/kg on 5th day | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 18. | ALA812905 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,ip) at the dose of 160 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA809231 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,ip) at the dose of 320 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA809232 | F | In vivo antitumor activity against the TLX5 lymphoma cell line in mouse species CBA/CA after intraperitoneal administration (inoculum cells-2x10E5,ip) at the dose of 80 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!